Wednesday, June 24, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 884 of 1,261
  1. US 8383805

    RNAi modulation of SCAP and therapeutic uses thereof

    The Board of Regents of the University of Texas System · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted
  2. US 8383858

    Processes and intermediates for preparing steric compounds

    Vertex Pharmaceuticals Incorporated · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted
  3. US 8383576

    LKKTET and/or LKKTNT peptide compositions which are lyophilized or in a form capable of being lyophilized

    REGENERX BIOPHARMACEUTICALS, INC. · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted
  4. US 8383580

    Methods of administering lipocalins to treat metabolic disorders and cardiovascular diseases

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted
  5. US 8383589

    Aegyptin and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted
  6. US 8383628

    Pyridyl derivatives and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted
  7. US 8383633

    Aminopyrimidines useful as kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted
  8. US 8383669

    Crystalline form of a 3-phenoxymethylpyrrolidine compound

    Theravance, Inc. · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted
  9. US 8383647

    Quinoline derivative

    Takeda Pharmaceutical Company Limited · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted
  10. US 8383665

    Immunomodulatory compositions

    Summit (Wales) Limited · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted
  11. US 8383785

    Anti-bacterial activity of 9-hydroxy derivatives of 6,11-bicyclolides

    Enanta Pharmaceuticals, Inc. · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted
  12. US 8377965

    Crystalline forms of a biphenyl compound

    Theravance, Inc. · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted
  13. US 8377884

    Variants of C-type natriuretic peptides

    BIOMARIN PHARMACEUTICAL INC. · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted
  14. US 8378109

    Labeled ALPHA4BETA2 ligands and methods therefor

    The Regents of the University of California · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted
  15. US 8377959

    Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

    ACADIA Pharmaceuticals Inc. · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted
  16. US 8377926

    Aminopyridine kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted
  17. US 8378124

    Preparation of protected alpha-keto beta-amino esters and amides

    Vertex Pharmaceuticals Incorporated · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted
  18. US 8378071

    Peptide epitopes of VEGFR-2/KDR that inhibit angiogenesis

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted
  19. US 8377637

    MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer using miR-17-3P

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted
  20. US 8377966

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted
  21. US 8378084

    Fusion molecule based on novel TAA variant

    The Regents of the University of California · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted
  22. US 8377872

    Cyclic P3 tripeptide hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted
  23. US 8377964

    Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists

    Theravance, Inc. · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted
  24. US 8377945

    Small molecule inhibitors of spleen tyrosine kinase (SYK)

    Rigel Pharmaceuticals, Inc. · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.